MedTrace Logo

H-28 DELTA ST-C and Minima Retrospective Study.

NCT05014113 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 95

Last updated 2021-08-20

No results posted yet for this study

Summary

The study aims to assess the clinical and radiographic outcomes of DELTA ST-C in combination with MINIMA stem at 3 years after primary THA surgery, and to evaluate the overall survivorship of the implant.

Conditions

  • Osteoarthritis, Hip

Interventions

DEVICE

DELTA-ST cup in combination with MINIMA stem

Advance articular destruction generated by primary degenerative or post-traumatic arthrosis or reumatoid arthritis; fracture or avascular necrosis; congenital or acquired deformity.

Sponsors & Collaborators

  • Limacorporate S.p.a

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-15
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05014113 on ClinicalTrials.gov